Literature DB >> 15043883

Listeria monocytogenes: comparative interpretation of mouse virulence assay.

Dongyou Liu1.   

Abstract

Being an opportunistic bacterial pathogen, Listeria monocytogenes demonstrates significant strain variations in virulence and pathogenicity. The availability of laboratory procedures to ascertain the pathogenic potential of L. monocytogenes bacteria would greatly enhance the control and prevention of listerial infections. As a method that measures all virulent determinants, mouse virulence assay has been frequently used for assessing L. monocytogenes virulence. The pathogenic potential of a given L. monocytogenes strain as determined by mouse virulence assay is often calculated from mouse mortality data in combination with colony forming units (CFUs) derived from plate counts, and expressed by medium lethal dose (LD(50)). In this report, we describe an alternative method [i.e., relative virulence (%)] that does not involve CFU estimation, and is comparable to LD(50) for interpretation of mouse virulence assay for L. monocytogenes. The relative virulence (%) is obtained by dividing the number of dead mice with the total number of mice tested for a particular strain using a known virulent strain (e.g., L. monocytogenes EGD) as reference. Besides providing a more direct interpretation in comparison with LD(50) values for mouse virulence assay, this method requires fewer dosage groups per L. monocytogenes strain, and eliminates CFU estimation that is step subject to variations between runs and also between laboratories.

Entities:  

Mesh:

Year:  2004        PMID: 15043883     DOI: 10.1016/j.femsle.2004.02.005

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  8 in total

1.  Listeria monocytogenes serotype 4b strains belonging to lineages I and III possess distinct molecular features.

Authors:  Dongyou Liu; Mark L Lawrence; Lisa Gorski; Robert E Mandrell; A Jerald Ainsworth; Frank W Austin
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

2.  Listeria monocytogenes subgroups IIIA, IIIB, and IIIC delineate genetically distinct populations with varied pathogenic potential.

Authors:  Dongyou Liu; Mark L Lawrence; Martin Wiedmann; Lisa Gorski; Robert E Mandrell; A Jerald Ainsworth; Frank W Austin
Journal:  J Clin Microbiol       Date:  2006-09-27       Impact factor: 5.948

3.  Internalin profiling and multilocus sequence typing suggest four Listeria innocua subgroups with different evolutionary distances from Listeria monocytogenes.

Authors:  Jianshun Chen; Qiaomiao Chen; Lingli Jiang; Changyong Cheng; Fan Bai; Jun Wang; Fan Mo; Weihuan Fang
Journal:  BMC Microbiol       Date:  2010-03-31       Impact factor: 3.605

4.  Prevalence, pathogenic capability, virulence genes, biofilm formation, and antibiotic resistance of Listeria in goat and sheep milk confirms need of hygienic milking conditions.

Authors:  Kamelia M Osman; Tara Rava Zolnikov; Ahmed Samir; Ahmed Orabi
Journal:  Pathog Glob Health       Date:  2013-12-19       Impact factor: 2.894

Review 5.  Animal models of listeriosis: a comparative review of the current state of the art and lessons learned.

Authors:  Karin Hoelzer; Régis Pouillot; Sherri Dennis
Journal:  Vet Res       Date:  2012-03-14       Impact factor: 3.683

Review 6.  Molecular approaches to the identification of pathogenic and nonpathogenic listeriae.

Authors:  Dongyou Liu
Journal:  Microbiol Insights       Date:  2013-07-22

7.  Characterization of the pathogenesis and immune response to Listeria monocytogenes strains isolated from a sustained national outbreak.

Authors:  Pallab Ghosh; Yan Zhou; Quentin Richardson; Darren E Higgins
Journal:  Sci Rep       Date:  2019-12-20       Impact factor: 4.379

8.  Molecular characterization and in vivo pathogenicity study of Listeria monocytogenes isolated from fresh and frozen local and imported fish in Jordan.

Authors:  Yaser Tarazi; Saeb El-Sukhon; Adil Al-Rahbi; Zuhair Bani Ismail
Journal:  Open Vet J       Date:  2021-09-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.